Jan. 24, 2013
/PRNewswire/ -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Star Scientific, Inc. ("Star Scientific" or the "Company")(NasdaqGM: STSI). The investigation focuses on whether the Company and its executives violated federal securities.
January 23, 2013
, shares of Star Scientific fell
or 11.74% to close at
after the street.com alleged that the Company misled investors about the involvement of
Johns Hopkins University
in the clinical testing of the company's retail nutritional supplement anatabine. According to a
Johns Hopkins School of medicine
spokesperson, the school has no official involvement with Star Scientific or anatabine. "The Antabloc Supplementation Autoimmune Prevention [ASAP] clinical study was not conducted at or approved by
said via email.
If you are aware of any facts relating to this investigation, or purchased shares of Star Scientific, you can assist this investigation by contacting either
of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email
. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.
Contact:Bronstein, Gewirtz & Grossman, LLC
SOURCE Bronstein, Gewirtz & Grossman, LLC